KCNN4 and head and neck squamous cell carcinoma: SKA-31, a selective KCa3.1 activator, enhanced antitumor immune responses in a humanized HNSCC mouse model generated by implanting Cal27 cells and healthy donor peripheral blood mononuclear cells into immunodeficient mice.